Search Results

News

Cannabis Use During Pregnancy Can Impact Thinking and Learning Skills, Increase Aggression Among Children, Study Shows

As cannabis is legalized and is more accessible in various forms across the country, there is increasing concern among health care providers about potential impact on children. Researchers at Nationwide Children’s Hospital have new findings to add to the existing evidence that cannabis exposure before birth can negatively impact children.

News

Nationwide Children's Hospital Ranked Among Top Hospitals in Ohio on Forbes List of “America’s Best Employers”

Nationwide Children’s Hospital has been named one of “America’s Best Employers” by Forbes for the fifth consecutive year.

News

Study: Youth Prescription Opioid Overdoses Increased During Early Stages of COVID-19 Pandemic

New research from experts at Nationwide Children’s Hospital shows a spike in emergency department visits among youth for prescription opioid overdoses during the early stages of the COVID-19 pandemic, highlighting the need for increased prevention efforts for children and teens.

Nationwide Children’s Hospital Renames Center for Gene Therapy, Honoring Jerry Mendell, MD
News

Nationwide Children’s Hospital Renames Center for Gene Therapy, Honoring Jerry Mendell, MD

Nationwide Children’s Hospital announced today the renaming and dedication of the Jerry R. Mendell, MD Center for Gene Therapy at the Abigail Wexner Research Institute, in honor of Jerry Mendell, MD, a pioneer in the fields of neurology and gene therapy and a catalyst for advancement in the treatment of multiple neuromuscular disorders.

Hematology
Specialty

Hematology

The Comprehensive Hemophilia and Bleeding Disorder Treatment Center at Nationwide Children's is the largest and only federally recognized pediatric Hemophilia Treatment Center (HTC) in Central Ohio. Our board certified hematologists and team will diagnose and treat your child in an environment where cutting edge advancements in blood disorders are taking place.

Jaimie D. Nathan, MD, Achieves Surgical Milestone: 100th TPIAT Procedure
News

Jaimie D. Nathan, MD, Achieves Surgical Milestone: 100th TPIAT Procedure

Nationwide Children’s Hospital congratulates Jaimie D. Nathan, MD, on a significant milestone in an advanced procedure known as a total pancreatectomy with islet autotransplantation (TPIAT). Dr. Nathan performed his 100th TPIAT on September 19, 2023.

New Initiative Aims to Improve Diagnosis and Treatment of Children with Solid Tumors Through Molecular Analysis
News

New Initiative Aims to Improve Diagnosis and Treatment of Children with Solid Tumors Through Molecular Analysis

The National Cancer Institute (NCI), part of the National Institutes of Health, Children’s Oncology Group (COG), and Nationwide Children's Hospital are poised to change the direction of pediatric cancer diagnosis and care. New results from international efforts to characterize pediatric cancers have led to the Molecular Characterization Initiative: a project that aims to collect, analyze, and report clinical molecular data to support COG-affiliated clinicians in choosing the best treatment for each child. This program is part of the NCI Childhood Cancer Data Initiative (CCDI).

2025 Ohio EMS for Children Conference

2025 Ohio EMS for Children Conference

Join us for the 2025 Annual Ohio EMS for Children Conference, focusing on the unique emergency care needs of children.

Dennis R. Durbin
Article

Dennis R. Durbin

Dennis R. Durbin, MD, MSCE, is president of the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital, a professor of Pediatrics at The Ohio State University College of Medicine and vice chair for Research in the Department of Pediatrics.

News

FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital

Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.

Most Popular Pages
Specialty

Asthma Program

Specialty

Clinical Therapies

Condition

Headaches

Condition

Nasal Congestion